A Phase I Clinical Study of Mitoxantrone Hydrochloride Liposome Injection in Combination With With Bortezomib and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Latest Information Update: 18 Apr 2025
At a glance
- Drugs Bortezomib (Primary) ; Bortezomib (Primary) ; Dexamethasone (Primary) ; Mitoxantrone liposomal (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
Most Recent Events
- 16 Jan 2022 Status changed from not yet recruiting to recruiting.
- 24 Sep 2021 New trial record